Overview
Thomas Beaudry practices practicing medicine in Winnipeg, Canada.
Mr. Beaudry is highly rated in 1 condition, according to our data. His clinical expertise encompasses Primary Amyloidosis, Dementia, and Alzheimer's Disease.
He is actively involved in clinical research, co-authoring 13 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Thomas Beaudry
Is Thomas Beaudry a top-rated expert for Primary Amyloidosis?
MediFind is an objective health platform that identifies experts based on real-world data. Thomas Beaudry is classified as an Advanced expert for Primary Amyloidosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Thomas Beaudry participate in research or clinical trials?
Yes. Thomas Beaudry has published 13 articles and abstracts on conditions like Primary Amyloidosis. You can view a list of Thomas Beaudry's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Primary AmyloidosisMr. Beaudry isAdvanced. Learn about Primary Amyloidosis.
- Experienced
- Alzheimer's DiseaseMr. Beaudry isExperienced. Learn about Alzheimer's Disease.
- DementiaMr. Beaudry isExperienced. Learn about Dementia.